Priya Sachdeva

Stock Analyst at UBS

(2.55)

# 2,138

Out of 5,173 analysts

6

Total ratings

83.33%

Success rate

17.51%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Buy	$18 → $22	$13.38	+64.42%	2	Dec 16, 2025
	PEN Penumbra	Maintains: Buy	$330 → $335	$335.56	-0.17%	4	Jul 30, 2025

NeuroPace

Dec 16, 2025

Maintains: Buy

Price Target: $18 → $22

Current: $13.38

Upside: +64.42%

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $335.56

Upside: -0.17%